Breakthrough hepatitis B virus infection and its associated factors among vaccinated children in Northwest Ethiopia

Despite the availability of an effective vaccine, the global prevalence of chronic hepatitis B (CHB) in children was estimated to range from 1.3 to 3.4%. In Ethiopia, the estimated seroprevalence of CHB in children under five years old was 2.21%. This study aimed to assess the prevalence of breakthrough hepatitis B virus (HBV) infection and its associated factors in northwest Ethiopia. A cross-sectional study was conducted in northwest Ethiopia from December 2023 to June 2024. Children aged 1-14 years who visited pediatric clinics for various medical reasons were enrolled. Hepatitis B surface antigen (HBsAg) was tested using an enzyme-linked immunosorbent assay (ELISA). Data were analyzed using SPSS version 23.0. Chi-square tests and logistic regression analyses were employed to identify predictors of breakthrough HBV infection, with statistical significance set at p < 0.05. Among 325 vaccinated children under 15 years of age, the prevalence of breakthrough HBV infection was 2.5% (95% CI: 0.9-4.3%). The age of the children and a history of contact with individuals with CHB were significantly associated with breakthrough infection. Children aged 5-9 years were 10.7 times (OR = 10.7; 95% CI: 1.1-99.6), and those aged 10-14 years were 20.7 times more likely to be infected with HBV (OR = 20.7; 95% CI: 2.0-215.8), compared to children aged 1-4 years. Additionally, children with a history of contact with CHB individuals were six times more likely to be infected with HBV (OR = 6.1; 95% CI: 1.4-27.6). This study found an intermediate prevalence of HBV infection among vaccinated children, which raises significant public health concerns. Age and contact with individuals with CHB were found to be significant factors associated with breakthrough HBV infection. These findings highlight the need for regular evaluation of the effectiveness of vaccination programs and the implementation of targeted preventive strategies to reduce transmission.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-08-28
DOI
https://doi.org/10.1038/s41598-025-02906-y
Citations
2
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
2.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Breakthrough hepatitis B virus infection and its associated factors among vaccinated children in Northwest Ethiopia

Mekuanint Geta, Asrat Hailu, Yimtubezinash Woldeamanuel
2 citations
Scientific Reports
Hepatitis B Virus Studies
2.71
article

Breakthrough hepatitis B virus infection and its associated factors among vaccinated children in Northwest Ethiopia

Mekuanint Geta, Asrat Hailu, Yimtubezinash Woldeamanuel
article en
2 citations

Abstract

Despite the availability of an effective vaccine, the global prevalence of chronic hepatitis B (CHB) in children was estimated to range from 1.3 to 3.4%. In Ethiopia, the estimated seroprevalence of CHB in children under five years old was 2.21%. This study aimed to assess the prevalence of breakthrough hepatitis B virus (HBV) infection and its associated factors in northwest Ethiopia. A cross-sectional study was conducted in northwest Ethiopia from December 2023 to June 2024. Children aged 1-14 years who visited pediatric clinics for various medical reasons were enrolled. Hepatitis B surface antigen (HBsAg) was tested using an enzyme-linked immunosorbent assay (ELISA). Data were analyzed using SPSS version 23.0. Chi-square tests and logistic regression analyses were employed to identify predictors of breakthrough HBV infection, with statistical significance set at p < 0.05. Among 325 vaccinated children under 15 years of age, the prevalence of breakthrough HBV infection was 2.5% (95% CI: 0.9-4.3%). The age of the children and a history of contact with individuals with CHB were significantly associated with breakthrough infection. Children aged 5-9 years were 10.7 times (OR = 10.7; 95% CI: 1.1-99.6), and those aged 10-14 years were 20.7 times more likely to be infected with HBV (OR = 20.7; 95% CI: 2.0-215.8), compared to children aged 1-4 years. Additionally, children with a history of contact with CHB individuals were six times more likely to be infected with HBV (OR = 6.1; 95% CI: 1.4-27.6). This study found an intermediate prevalence of HBV infection among vaccinated children, which raises significant public health concerns. Age and contact with individuals with CHB were found to be significant factors associated with breakthrough HBV infection. These findings highlight the need for regular evaluation of the effectiveness of vaccination programs and the implementation of targeted preventive strategies to reduce transmission.

Scientific ReportsVol. 15(1)
Africa Centres for Disease Control and Prevention (ET), Addis Ababa University (ET), University of Gondar (ET)
Openalex Percentile: Top 9%
Hepatitis B Virus Studies
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.